{"id":987508,"date":"2026-07-30T16:07:44","date_gmt":"2026-07-30T20:07:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/"},"modified":"2026-07-30T16:07:44","modified_gmt":"2026-07-30T20:07:44","slug":"praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/","title":{"rendered":"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON, July  30, 2026  (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it will report its financial results for the second quarter ended June 30, 2026 and provide a corporate update, before the financial markets open on Thursday, August 6, 2026.<\/p>\n<p>The Company will host a conference call and a live webcast to review the second quarter financial results and provide a corporate update on Thursday, August 6, 2026, at 8:30 am ET, which can be accessed by visiting this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FjQNIHTcf2JPr9mU3o9gJXBmvZ0zq76E2f798_V-aZj3JwQG8DX4FfZEIrup4YES-fXGZ9Z_aRogtiUpNA7ev5mKmSlEjLfg_3UYiGiWQKyxTRtU39kbxFhwApdLkqlo\" rel=\"nofollow\" target=\"_blank\">registration link<\/a>. The live webcast will also be available through the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zXWrPiNG0IQekDmbgGDev_CUqvuVXCkuBb3Mf-vQ7UUP2FAg5CPkMOHdD75q7kX-xxeyZnKhcJHB-TBMbu-XlKgF9DrAITEba-uTFg-UCI_AuLhzPKmul-brR1doDlbCfDccwC4tllgLP8UvkpNCEylgY4oiPijmOgatwpvPMSk=\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a> page of the Investors + Media section of the company\u2019s website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OWhi8VdSCB8C0pwrH_JxZxpmlWYtDpD-KSwlxf92CfTqjy5PFYEA0He1yGk-udcqW_VuoNnIw1tOWrxN2KdJlymUKr7xZbQqT48lFkXhnCQ=\" rel=\"nofollow\" target=\"_blank\">www.praxismedicines.com<\/a>.<\/p>\n<p>A replay of the second quarter earnings webcast will be available on Praxis\u2019 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zXWrPiNG0IQekDmbgGDev_CUqvuVXCkuBb3Mf-vQ7UUKo-oWrhPNMzQ0Hl6Hw4MICTRtv_KkjiSfYlIE4j73qt90hBPOkkpzr1o0svfvZ5X5ShOhGqGFIHp6LrtDfce3NfexSKqzMyvXqDwakZXnx26W3-twuFDF1p0hmCHjN10=\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a> page of the company\u2019s website after each event for approximately 90 days.<\/p>\n<p>\n        <strong>About Praxis<\/strong><br \/>\n        <br \/>Praxis Precision Medicines is a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum\u2122, and antisense oligonucleotide (ASO) platform, Solidus\u2122, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across movement disorders and epilepsy, with four late-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XocdoAEvhGnzOe1YBQIUv7Xrw_NzEr-2FTLsk1buNrIDgNytox2CyQiLATQx4ExzVReWRN2nsgEwHFYy_ptt1VKGDybC0aMujYpqikGCmS5ESXFdxQ4CoAok_upv8yua\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QECstc_V-eMLLrLlTe78HHm6iCGlr-FFClnaZ44P_IvybvETs6yt3oA5VURN3NMMhkG8w0E6GbPvldyHcjz1wDVv90X67w4gIQ1xTBk9rsg=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O3uyMv2ZetCAGT8vYJOmblGfTx36L04-UZHwKmExRuX8JQMSH7ukxvhD7wetxcOida9Vu_sDTqZD7--u4iJlj4lfXOSAvE0VxzZDOt0ejUlZ6GsWXs0VcxrnejCg06nUOv5x1MC5HtC8YoXLLFim_g==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tSJiN8iMdwEQk8v63Zr4BBBbpi9VLFh6rofFGsim_Vu8R0Va-ZRTw4rUL3GpXu0DwLo6KiBnk4uNe3528UrI4-mFbDx3a8-sF9ETH_qy-dM=\" rel=\"nofollow\" target=\"_blank\">Twitter\/X<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGJkOTY0ZGQtNWEyOS00MGNkLTg2YTEtODZjYTlhNzI1MmIwLTEyMTI0NDktMjAyNi0wNy0zMC1lbg==\/tiny\/Praxis-Precision-Medicines-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Contact:\u00a0\r\nPraxis Precision Medicines\u00a0\r\ninvestors@praxismedicines.com\u00a0\r\n857-702-9452\u00a0\r\n\u00a0\r\nMedia Contact:\r\nDan Ferry\r\nLifeSci Advisors\r\nDaniel@lifesciadvisors.com\r\n617-430-7576<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, July 30, 2026 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it will report its financial results for the second quarter ended June 30, 2026 and provide a corporate update, before the financial markets open on Thursday, August 6, 2026. The Company will host a conference call and a live webcast to review the second quarter financial results and provide a corporate update on Thursday, August 6, 2026, at 8:30 am ET, which can be accessed by visiting this registration link. The live webcast will also be available through the Events &amp; Presentations page of the Investors + Media section of the company\u2019s website &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-987508","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, July 30, 2026 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it will report its financial results for the second quarter ended June 30, 2026 and provide a corporate update, before the financial markets open on Thursday, August 6, 2026. The Company will host a conference call and a live webcast to review the second quarter financial results and provide a corporate update on Thursday, August 6, 2026, at 8:30 am ET, which can be accessed by visiting this registration link. The live webcast will also be available through the Events &amp; Presentations page of the Investors + Media section of the company\u2019s website &hellip; Continue reading &quot;Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-30T20:07:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026\",\"datePublished\":\"2026-07-30T20:07:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/\",\"name\":\"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY=\",\"datePublished\":\"2026-07-30T20:07:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/","og_locale":"en_US","og_type":"article","og_title":"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - Market Newsdesk","og_description":"BOSTON, July 30, 2026 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it will report its financial results for the second quarter ended June 30, 2026 and provide a corporate update, before the financial markets open on Thursday, August 6, 2026. The Company will host a conference call and a live webcast to review the second quarter financial results and provide a corporate update on Thursday, August 6, 2026, at 8:30 am ET, which can be accessed by visiting this registration link. The live webcast will also be available through the Events &amp; Presentations page of the Investors + Media section of the company\u2019s website &hellip; Continue reading \"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-30T20:07:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026","datePublished":"2026-07-30T20:07:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/","name":"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY=","datePublished":"2026-07-30T20:07:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMTE2NSM3NzUxNzIxIzIyMDA4OTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/praxis-precision-medicines-to-report-second-quarter-2026-financial-results-on-thursday-august-6-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/987508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=987508"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/987508\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=987508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=987508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=987508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}